dr. vogelzang discusses cabozantinib trial design
Published 13 years ago • 158 plays • Length 1:35Download video MP4
Download video MP3
Similar videos
-
1:34
dr. vogelzang discusses the cabozantinib trial design
-
1:36
dr. vogelzang discusses mortalities in cabozantinib trial
-
1:45
dr. vogelzang discusses cabozantinib's dose size
-
0:56
dr. vogelzang on cabozantinib clinical trial results
-
1:14
dr. vogelzang describes cabozantinib's side effects
-
0:59
dr. ezra cohen discusses the cabozantinib exam trial
-
1:34
dr. vogelzang discusses prospect trial for prostate cancer
-
2:22
nicholas vogelzang, md, discusses re-emergence of dose reduced cabozantinib alezotuzumab in apc
-
5:53
david emerson
-
8:15
resect trial
-
48:37
breakthroughs in prostate and bladder cancer treatment - full video
-
1:11
dr. vogelzang on xl184's effect on bone metastases
-
6:00
clinical rationale for cabozantinib in hcc
-
1:16
dr. ezra cohen discusses the cabozantinib dose size and tolerability
-
1:27
dr. ezra cohen on the efficacy and pharmacokinetics of cabozantinib
-
0:57
dr. tolaney on trials investigating cabozantinib in breast cancer
-
1:53
dr. nicholas vogelzang discusses sequencing abiraterone and enzalutamide
-
3:41
checkmate 9er: phase 3 trial of frontline nivolumab cabozantinib
-
1:12
dr. vogelzang discusses mpdl3280a in patients with metastatic urothelial bladder cancer
-
4:12
cabosun trial of cabozantinib - could it change how we treat frontline rcc?
-
1:22
dr. grigg discusses cabosun trial in mrcc
-
1:47
current and upcoming clinical trials in bladder cancer